Probiotics for the Prevention of COVID-19 Sequelae
- PMID: 36030115
- PMCID: PMC9402282
- DOI: 10.1016/j.arcmed.2022.08.004
Probiotics for the Prevention of COVID-19 Sequelae
Conflict of interest statement
Competing Interest All authors declare no conflicts of interest.
Comment in
-
Reply to: Probiotics for the Prevention of COVID-19 Sequelae.Arch Med Res. 2022 Sep;53(6):644. doi: 10.1016/j.arcmed.2022.08.005. Epub 2022 Aug 15. Arch Med Res. 2022. PMID: 35999061 Free PMC article. No abstract available.
Comment on
-
Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.Arch Med Res. 2021 Aug;52(6):582-594. doi: 10.1016/j.arcmed.2021.03.002. Epub 2021 Mar 19. Arch Med Res. 2021. PMID: 33785208 Free PMC article. Review.
References
-
- de Almeida VM, Engel DF, Ricci MF, et al. 2022. Preprint. ResearchSquare; pp. rs.3.rs–1756189.
-
- Arnbjerg CJ, Vestad B, Hov JR, et al. Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2018;78:450–457. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
